Journal of the American College of Cardiology

Volume 38, Issue 7, December 2001 DOI: 10.1016/S0735-1097(01)01673-4

The healing process of infarct-related plaques
Insights from 18 months of serial angioscopic follow-up

Yasunori Ueda, Masanori Asakura, Osamu Yamaguchi, Atsushi Hirayama, Masatsugu Hori and Kazuhisa Kodama

Table 4

Table 4

Patient Characteristics for Figure 4

	Post-Reperfusion
	Immediately		1 Month		6 Months		18 Months
	W/O DM (n = 29)	With DM (n = 24)	W/O DM (n = 20)	With DM (n = 27)	W/O DM (n = 8)	With DM (n = 13)	W/O DM (n = 9)	With DM (n = 8)
Age (yrs)	62	62	60	61	64	61	65	66
Gender (male	23 (79%)	17 (71%)	17 (85%)	19 (70%)	7 (88%)	7 (54%)	7 (78%)	4 (50%)
Multi-vessel disease	16 (55%)	10 (42%)	9 (45%)	10 (37%)	4 (50%)	4 (31%)	4 (44%)	4 (50%)
Coronary risk factors
Hypertension	13 (45%)	11 (46%)	12 (60%)	10 (37%)	3 (38%)	6 (46%)	3 (33%)	2 (25%)
Hyperlipidemia	21 (72%)	11 (46%)	10 (50%)	17 (63%)	5 (63%)	9 (69%)	6 (67%)	8 (100%)
Smoking	3 (10%)	2 (8%)	2 (10%)	3 (11%)	1 (13%)	2 (15%)	1 (11%)	1 (13%)
Obesity	2 (7%)	3 (13%)	2 (10%)	5 (19%)	0	2 (15%)	0	1 (13%)
Serum lipid levels
Total cholesterol (mg/dl)	228	206	204	220	212	232	222	218
HDL cholesterol (mg/dl)	45	45	46	45	46	48	52	46
Triglycerides (mg/dl)	139	146	111	148	100	135	119	153
Medications
Beta-blockers	3 (10%)	3 (13%)	1 (5%)	1 (4%)	2 (25%)	1 (8%)	1 (11%)	0 (0%)
ACE inhibitors	20 (69%)	14 (58%)	12 (60%)	15 (56%)	4 (50%)	7 (54%)	6 (67%)	5 (63%)
Nitrate	27 (93%)	22 (92%)	18 (90%)	24 (89%)	7 (88%)	12 (92%)	7 (78%)	6 (75%)
Calcium blockers	16 (55%)	15 (63%)	10 (50%)	16 (59%)	7 (88%)	10 (77%)	5 (56%)	5 (63%)
Antiplatelet drugs	27 (93%)	23 (96%)	19 (95%)	26 (96%)	8 (100%)	13 (100%)	9 (100%)	7 (88)
Lipid-lowering drugs	17 (59%)	7 (29%)	6 (30%)	10 (37%)	2 (25%)	5 (38%)	4 (44%)	7 (88%)

Data are presented as the mean value or number (%) of patients.

DM = diabetes mellitus; W/O = without; other abbreviations as in Table 1.

Advertisement